Skip to main content

Month: December 2020

WeCommerce Holdings Ltd. Announces Closing of Qualifying Transaction

NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATESVANCOUVER, British Columbia, Dec. 09, 2020 (GLOBE NEWSWIRE) — WeCommerce Holdings Ltd. (formerly, Brachium Capital Corp.) (the “Company”) (TSXV: WE) is pleased to announce that it has completed its previously announced “Qualifying Transaction” (as defined by Policy 2.4 of the TSX Venture Exchange (the “Exchange“)) involving a three cornered amalgamation where WeCommerce Holdings Ltd., a private British Columbia Corporation, (“WeCommerce”), was amalgamated with a wholly-owned subsidiary of the Company (the “Qualifying Transaction”). In addition, the Company is pleased to announce the conversion and exchange of the subscription receipts (the “Subscription Receipts”) issued in connection with WeCommerce’s previously announced...

Continue reading

Codorus Valley Bancorp, Inc. Completes $31.0 Million Subordinated Debt Offering

YORK, Pa., Dec. 09, 2020 (GLOBE NEWSWIRE) — Codorus Valley Bancorp, Inc. (“Codorus Valley” or the “Company”) (NASDAQ: CVLY), the parent company for PeoplesBank, A Codorus Valley Company (“PeoplesBank”), which is the parent company of PeoplesWealth Advisors, today announced the completion of a private placement of $31.0 million in aggregate principal amount of 4.50% Fixed-to-Floating Rate Subordinated Unsecured Notes due 2030 (the “Notes”). The Company intends to utilize the net proceeds for general corporate purposes.“We are pleased to announce the successful completion of our subordinated debt offering under favorable terms. This debt offering will strengthen the Company’s already strong capital position, provide additional flexibility as we grow our franchise and it will enhance our ability to execute on our long-term business...

Continue reading

Avid Bioservices Announces Proposed Public Offering of Common Stock

TUSTIN, Ca., Dec. 09, 2020 (GLOBE NEWSWIRE) — Avid Bioservices, Inc. (NASDAQ:CDMO) (NASDAQ:CDMOP), a dedicated biologics contract development and manufacturing organization (CDMO) working to improve patient lives by providing high quality development and manufacturing services to biotechnology and pharmaceutical companies, today announced that it has commenced an underwritten public offering of its common stock. Avid Bioservices, Inc. also intends to grant the underwriters a 30-day option to purchase from it up to an additional 15% of the shares of common stock offered in the public offering. Avid Bioservices, Inc. intends to use the net proceeds from the offering primarily for the expansion of its manufacturing capabilities and any remainder for general corporate purposes.RBC Capital Markets is acting as sole book-running manager...

Continue reading

Noront Resources Announces Director Resignation

TORONTO, Dec. 09, 2020 (GLOBE NEWSWIRE) — Noront Resources Ltd. (“Noront” or the “Company”) (TSX Venture: NOT) announced today that Gregory Honig, Director of Origination, Canada, Resource Capital Funds (“RCF”) has resigned from the Company’s Board of Directors.   Mr. Honig’s resignation follows the recently announced agreement that will result in the sale of Resource Capital Fund V L.P.’s beneficial equity and debt interests in Noront Resources to Wyloo Metals Pty Ltd.Noront Chairman Paul Parisotto said, “On behalf of the Noront Board of Directors and Management team, I would like to thank Mr. Honig for his service and extend our appreciation to RCF which was a cornerstone investor in Noront for many years. Their confidence in us and their support was invaluable in helping us advance our projects in the Ring of Fire.”About Noront...

Continue reading

G1 Therapeutics Presents Final Phase 2 Clinical Data on Trilaciclib in Combination with Chemotherapy in Metastatic Triple-Negative Breast Cancer Demonstrating Significant Improvement in Overall Survival at 2020 San Antonio Breast Cancer Symposium

RESEARCH TRIANGLE PARK, N.C., Dec. 09, 2020 (GLOBE NEWSWIRE) — G1 Therapeutics, Inc. (Nasdaq: GTHX), a clinical-stage oncology company, today reported final data from its randomized Phase 2 trial of trilaciclib in metastatic triple-negative breast cancer (mTNBC) showing that trilaciclib significantly improved overall survival (OS) for patients treated with trilaciclib in combination with a chemotherapy regimen of gemcitabine/carboplatin (GC) compared with GC alone. These data were presented in a Spotlight Poster Discussion Session at the 2020 San Antonio Breast Cancer Symposium (SABCS). Trilaciclib is a first-in-class investigational therapy designed to improve outcomes for people with cancer treated with chemotherapy.“Triple-negative breast cancer is the most aggressive form of breast cancer, and there is a significant need for...

Continue reading

Alamos Gold Provides 2021 Production and Operating Guidance

All amounts are in United States dollars, unless otherwise stated.TORONTO, Dec. 09, 2020 (GLOBE NEWSWIRE) — Alamos Gold Inc. (TSX:AGI; NYSE:AGI) (“Alamos” or the “Company”) today provided 2021 production and operating guidance.“This has been a transformational year for Alamos. Operationally, we continue to execute and remain on track to achieve our 2020 production, cost, and capital guidance. We also delivered on several significant catalysts which have solidified our strong outlook. We completed the lower mine expansion at Young-Davidson, transitioned to strong free cash flow generation in the third quarter, and began construction on the high-return La Yaqui Grande project and Phase III Expansion at Island Gold,” said John A. McCluskey, President and Chief Executive Officer.“The ramp up of mining rates at Young-Davidson is expected...

Continue reading

Eloro Resources Announces Upsize to Previously Announced Bought Deal Financing to C$5.5 Million

NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR RELEASE, PUBLICATION, DISTRIBUTION OR DISSEMINATION DIRECTLY, OR INDIRECTLY, IN WHOLE OR IN PART, IN OR INTO THE UNITED STATES.TORONTO, Dec. 09, 2020 (GLOBE NEWSWIRE) — Eloro Resources Ltd. (the “Company” or “Eloro”) (TSX-V: ELO; OTCQX: ELRRF; FSE: P2QM) is pleased to announce that it has amended the terms of its previously announced bought deal financing to increase the size of the offering to C$5.5 million (the “Upsized Offering”).Under the terms of the Upsized Offering, a syndicate of underwriters led by Haywood Securities Inc. (“Haywood”), and including Echelon Wealth Partners Inc. (together with Haywood, the “Underwriters”) have agreed to purchase, on a bought deal basis, 3,548,400 units (the “Units”) at a price of C$1.55 per Unit (the “Issue Price”) for gross proceeds to...

Continue reading

U.S. Silicon Metal Producers Welcome Duties on Unfairly Traded Silicon Metal Imports From Bosnia and Herzegovina, Iceland

MIAMI, Dec. 09, 2020 (GLOBE NEWSWIRE) — Globe Specialty Metals, Inc. (“GSM”), a subsidiary of Ferroglobe PLC (NASDAQ: GSM), and Mississippi Silicon LLC (“MS”), together representing the majority of American silicon metal production, welcomed news on December 8th that the U.S. Department of Commerce (“Commerce”) will impose preliminary duties of up to 47.54% on all silicon metal imports from Iceland and Bosnia and Herzegovina.This announcement is the latest development in ongoing investigations of unfairly-traded silicon metal imports from Bosnia and Herzegovina, Iceland, Malaysia and Kazakhstan and closely follows an announcement that Commerce will impose preliminary duties up to 120% on all silicon metal import from Kazakhstan. In August, the U.S. International Trade Commission (“ITC”) preliminarily determined that...

Continue reading

Globus Medical Trauma Division Awarded Purchasing Agreement with Premier Inc.

AUDUBON, Pa., Dec. 09, 2020 (GLOBE NEWSWIRE) — Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal solutions company, was recently awarded a group purchasing agreement with Premier, one of the largest group purchasing organizations in the United States. The agreement covers Globus’ Trauma Platform, which includes ANTHEM® Plating, AUTOBAHN® Nailing, ARBOR® External Fixation, and CAPTIVATE® Screw Platforms.“We are very pleased that Premier has selected Globus Medical as a contracted supplier for our Trauma Platform,” said Dan Scavilla, Executive Vice President, Chief Commercial Officer & President, Trauma. “Our mission is to become the pre-eminent musculoskeletal company in the world by expanding our presence in spine, imaging navigation and robotics, trauma, and joint reconstruction in support of strong healthcare...

Continue reading

Goodfood Market Corp. CEO & Chairman and President & COO Establish Automatic Securities Disposition Plans

MONTREAL, Dec. 09, 2020 (GLOBE NEWSWIRE) — Goodfood Market Corp. (“Goodfood” or “the Company”) (TSX: FOOD), a leading online grocery company in Canada, announced today that each of Chief Executive Officer and Chairman Jonathan Ferrari and President and Chief Operating Officer, Neil Cuggy, have established Automatic Securities Disposition Plans (“ASDPs”) in accordance with applicable Canadian securities legislation, including guidance under Ontario Securities Commission Staff Notice 55-701 and the Company’s Disclosure Policy.The ASDPs will allow for an orderly disposition of a small portion of each of Mr. Ferrari’s and Mr. Cuggy’s shares in Goodfood at prevailing market prices for personal financial planning purposes.Each of Mr. Ferrari and Mr. Cuggy intends to have up to 375,000 common shares sold under their ASDP, which represents...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.